跳至主要内容
临床试验/NCT06646263
NCT06646263Enrolling By Invitation不适用

Cellular Immune Responses in Triple-negative Breast Cancer - High Throughput Immunogenetic Studies

Institute of Applied Biosciences1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2024年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
发起方
入组人数
150
试验地点
1
主要终点
T cell receptor profiling as a potential biomarker in Triple-Negative Breast Cancer

研究概览

简要总结

This project introduces a novel methodology for the in-depth immunogenetic characterization of the TR gene repertoire in solid tumors, holding the promise to offer unprecedented insights into the TR anti-tumor specificity and the prognostic/predictive value of TR gene repertoire signatures.

详细描述

The goal of this observational study is to address the role of T cells in the tumor microenvironment of TNBC.

In detail, this study aims to:

(i) explore the immunogenetic characteristics of the TR gene repertoire as informative prognostic/predictive biomarkers in TNBC (ii) identify immunogenic neoepitopes arising from common tumor-specific non-synonymous gene mutations, as well as the corresponding neoepitope-specific T cells (iii) describe, in single-cell resolution, the spatial organization of the intricate crosstalk between tumor cells and neoepitope specific-T cells, and (iv) delineate the functional properties of T cells within the TME.

All the experimental results, regarding the TR repertoire features and the spatial organization of the TME, will be correlated with clinical outcome measurements (e.g. overall survival, progression time), which are available from the detailed patients medical record.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
Female
接受健康志愿者
否

入选标准

  • •Confirmed TNBC diagnosis

排除标准

  • 未提供

结局指标

主要结局

T cell receptor profiling as a potential biomarker in Triple-Negative Breast Cancer

时间窗: 4 years

次要结局

未报告次要终点

研究者

发起方
Institute of Applied Biosciences
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验